The inhibition of ribonuclease by acidic polymers and their use as possible antiviral agents. 1958

Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER

UI MeSH Term Description Entries
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000143 Acids Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed) Acid
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012260 Ribonucleases Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-. Nucleases, RNA,RNase,Acid Ribonuclease,Alkaline Ribonuclease,Ribonuclease,RNA Nucleases,Ribonuclease, Acid,Ribonuclease, Alkaline
D014780 Viruses Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. Animal Viruses,Zoophaginae,Animal Virus,Virus,Virus, Animal,Viruses, Animal

Related Publications

Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
January 2016, Folia microbiologica,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
December 1959, Archives of biochemistry and biophysics,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
September 2006, Expert opinion on drug delivery,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
May 1974, The Western journal of medicine,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
September 1958, The Journal of biological chemistry,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
July 1955, Journal of bacteriology,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
October 2003, Medicina clinica,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
May 1994, L'union medicale du Canada,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
September 2017, International journal of biological macromolecules,
Z R GULICK, and H HEYMANN, and C J DE BOER, and G DE STEVENS, and R L MAYER
January 2010, Reviews in medical virology,
Copied contents to your clipboard!